Inactief instrument

Andere talen The Greater Cannabis Company, Inc. Other OTC

Aandelen

GCAN

US3916571033

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

The Greater Cannabis Company, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	14/05
The Greater Cannabis Company, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	01/04
GCANRx Announces Completion of Preclinical Study for Neuropsychiatric Cannabinoid Therapy	27/02
The Greater Cannabis Company, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13/11
GCANRx Featured in American Journal of Endocannabinoid Medicine	21-09-23
The Greater Cannabis Company, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14-08-23
Nanocap Potential Breakout Watchlist (EPAZ, GCAN, IQST, ONCR)	06-07-23
GCANRx Announces Approval of Phase II Clinical Trial to Treat Autism Related Spectrum Disorders	05-07-23
The Greater Cannabis Company, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	12-05-23
GREATER CANNABIS COMPANY, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	13-04-23
The Greater Cannabis Company, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	13-04-23
The Greater Cannabis Company, Inc. Auditor Raises 'Going Concern' Doubt	13-04-23
Greater Cannabis : Change in Certifying Accountants - Form 8-K	26-01-23
GREATER CANNABIS COMPANY, INC. : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)	26-01-23
GREATER CANNABIS COMPANY, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	14-11-22
The Greater Cannabis Company, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14-11-22
GCANRx Announces Submission of Phase 2 Clinical Trial Application to Treat Autism Related Spectrum Disorders	07-10-22
GCANRx Announces Submission of Phase 2 Clinical Trial Application to Treat Autism Related Spectrum Disorders	07-10-22
Greater Cannabis Company, Inc. Announces Submission of Phase 2 Clinical Trial Application to Treat Autism Related Spectrum Disorders	07-10-22
GREATER CANNABIS COMPANY, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	16-08-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen The Greater Cannabis Company, Inc. Other OTC

Aandelen

GCAN

US3916571033

Andere talen

Filters